Alexandra Ellervik
Investor Relations Contact chez CHOSA ONCOLOGY AB
Profil
Alexandra Ellervik is currently the Head of Communication & Investor Relations at Chosa Oncology AB.
Previously, she worked as an Investor Relations & Press Contact at RhoVac AB.
Postes actifs de Alexandra Ellervik
| Sociétés | Poste | Début |
|---|---|---|
| CHOSA ONCOLOGY AB | Investor Relations Contact | - |
Anciens postes connus de Alexandra Ellervik
| Sociétés | Poste | Fin |
|---|---|---|
| CHOSA ONCOLOGY AB | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHOSA ONCOLOGY AB | Commercial Services |
| Entreprise privées | 1 |
|---|---|
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
